Current Mentors

Research Interests of Current Mentors:


John Brabyn, Ph.D.
Low vision and blindness rehabilitation, sensory impairment, assistive technology.

Arvind Chandna, M.D., D.O., F.R.C.S., F.R.C.Ophth.                                      
Childhood vision disorders, particularly neural correlates in adult and childhood strabismus and associated eye movements, amblyopia and vision impairment from cerebral injury in babies.

James Coughlan, Ph.D.                                                                                              
Applications of computer vision and sensor technologies for people who are blind or visually impaired.

Don Fletcher, M.D.
Low vision rehabilitation, correlation of macular pathology to functional performance, macular perimetry, reading, and adaptive skill training.

Bill Good, M.D.
Abnormal visual development in infants and children.

Steve Heinen, Ph.D.
Motion and attention contributions to smooth and fixational eye movements in normals and individuals with central field loss.

Chuan Hou, M.D., Ph.D.
EEG source imaging and psychophysical studies of interocular suppression and attention, temporal dynamics of visual processing in amblyopia and strabismus.

Lora Likova, Ph.D.
Brain imaging of learning, memory and brain plasticity in the blind and the sighted, sensorimotor processing, neurorehabilitation, cross-modal brain reorganization, visual deficits in mTBI.

Lori Lott, Ph.D.
Visual function and reading in normal aging and early to intermediate age-related macular degeneration.

Josh Miele, Ph.D.
Accessible information systems, audio/tactile interfaces, auditory displays, video accessibility, and mobile technologies for the blind and visually impaired.

Christopher Tyler, Ph.D., D.Sc. 

Psychophysical, oculomotor, EEG and functional MRI studies of binocular vision, long-range interactions, and temporal dynamics of visual processing in visual processing disorders.

Preeti Verghese, Ph.D.
Psychophysics and EEG source imaging of spatial vision and attention; eye movements in normal vision and in individuals with central field loss.